Cytokines and the Acute Phase Response in SLE

Schultz DR , Arnold PI Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, alphal-acid glycoprotein and fibrinogen. Semin Arthratis Rheum 1990; 20: 129-47.

Andus T. , Geiger T. , Hirano T. , Kishimoto T. , Heinrich PC Action of recombinant human interleukin 6, interleukin lbeta and tumour necrosis factor alpha on the mRNA induction of acute phase proteins. Eur J Immunol 1988; 18: 739-46.

Heinrich PC , Castell JV , Andus T. Interleukin-6 and the acute phase response. Biochem J 1990; 265: 621-36.

Steel DM , Whitehead AS Heterogeneous modulation of acute-phase-reactant mRNA levels by interleukin-lbeta and interleukin-6 in the human hepatoma cell line PLC/PRF/5. Biochem J 1991; 277: 477-82.

Van Damme J , Opdenakker G. , Simpson RJ et al. Identification of the human 26-kD protein, interferon beta2 (IFN-ß2), as a ß cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor. J Exp Med 1987 ; 165: 914-19.

Brouckaert P. , Spriggs DR , Demetri G. , Kufe DW , Fiers W. Circulating interleukin-6 during a continuous infusion of tumor necrosis factor and interferon gamma . J Exp Med 1989; 169: 2257-62.

McIntosh JK , Jablons DM , Mule JJ et al. In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumour-bearing mice. J Immunol 1989; 143: 162-7.

Castell JV , Gomez-Lechon MJ , David M. et al. Interleukin-6 is the main regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett 1989 ; 242: 237-9.

Ganter U. , Arcone R. , Toniatti C. , Morrone G. , Ciliberto G. Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6 . EMBO J 1989; 8: 3773-9.

Nijsten Mwn , de Groot ER , ten Duis HJ , Klasen HJ , Hack CE , Aarden LA Serum levels of interleukin-6 and acute phase responses. Lancet 1987; ii: 921.

Nishimoto N. , Yoshizaki K. , Tagoh H. et al. Elevation of serum interleukin 6 prior to acute phase proteins on the inflammation by surgical operation. Clin Immunol Immunopathol 1989 ; 50: 399-401.

Ulich TR , Guo K. , Remick D. , del Castillo J. , Yin S. Endotoxin-induced cytokine gene expression in vivo. III. IL-6 mRNA and serum protein expression and the in vivo haematologic effects of IL-6. J Immunol 1991; 146: 2316-23.

Shalaby MR , Waage A. , Aarden L. , Espevick T. Endotoxin , tumor necrosis factor alpha and interleukin 1 induce interleukin 6 production in vivo. Clin Immunol Immunopathol 1989; 53: 488-98.

Waage A. , Halstensen A. , Shalaby R. , Brandtzaeg P. , Kierulf P. , Espevik T. Local production of tumor necrosis factor alpha, interleukin 1 and interleukin 6 in meningococcal meningitis. J Exp Med 1989 ; 170: 1859-67.

Pepys MB , Lanham JG , De Beer FC. C-reactive protein in SLE. Clin Rheum Dis 1982; 8: 91-103.

ter Borg EJ , Horst G. , Limburg PC , Rijswijk MH , Kallenberg Cgm. C-reative protein levels during disease exacerbations and infections in systemic lupus erythematosus: a prospective longitudinal study. J Rheumatol 1990 ; 17: 1642-8.

Spronk PE , ter Borg EJ , Kallenberg Cgm. Patients with systemic lupus erythematosus and Jaccoud's arthropathy: a clinical subset with an increased C-reactive protein response? Ann Rheum Dis 1992; 51: 358-61.

Pepys MB C-reactive protein fifty years on. Lancet 1981; i: 653-57.

Meijer C. , Huysen V. , Smeenk Rtj , Swaak Ajg. Profiles of cytokines (TNFα and IL-6) and acute phase proteins (CRP and α1AG) related to the disease course in patients with systemic lupus erythematosus . Lupus 1993; 2: 359-65.

Swaak Ajg , Van Rooyen A , Aarden LA Interleukin-6 (IL-6) and acute phase proteins in the disease course of patients with systemic lupus erythematosus. Rheumatol Int 1989; 8: 263-8.

Swaak Ajg , Sintnicolaas C. , Meijer C. , Smeenk RT Observations on the interleukin-6 and acute phase protein profiles in the disease course of patients with lupus erythematosus. Lupus 1992; 1: 151-155.

Maury Cpj , Teppo A-M. Tumor necrosis factor in the serum of patients with systemic lupus erythematosus . Arthritis Rheum 1989; 32: 146-50.

Yu C-L. , Chang K-L. , Chiu C-C. , Chiang BN , Han S-H. , Wang S-R. Defective phagocytosis, decreased tumour necrosis factor-alpha production and lymphocyte hyporesponsiveness to infections . Scand J Rheumatol 1989; 18: 97-105.

Aderka D. , Wysenbeck A. , Engelmann H. et al. Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus. Arthritis Rheum 1993; 36: 1111-20.

Linker-Israeli M. , Deans RJ , Wallace DJ , Prehn J. , Oxzeri-Chen T. , Klinberg JR Elevated levels of endogenous IL-6 in systemic lupus erythematosus. J Immunol 1991; 147: 117-23.

Spronk PE , ter Borg EJ , Limburg PC , Kallenberg Cgm. Plasma concentration of IL-6 systemic lupus erythematosus; an indicator of disease activity. Clin Exp Immunol 1992 ; 90: 106-110.

Gabay C. , Roux-Lombard P. , de Moerloose P. , Dayer J-D. , Vischer T. , Gueme P-A. Absence of correlation between interleukin 6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis . J Rheumatol 1993 ; 20: 815-21.

Metsarinne KP , Nordstrom Cde , Konttinen YT , Teppo A-M. , Fyhrquist FY Plasma interleukin-6 and renin substrate in reactive arthritis, rheumatoid arthritis and systemic lupus erythematosus . Rheumatol Int 1992; 12: 93-6.

Gordon C. , Richards N. , Howie AJ et al. Urinary IL-6: a marker for mesangial proliferative glomerulonephritis . Clin Exp Immunol 1991; 86: 145-9.

Kitani A. , Hara M. , Hirose T. et al. Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression. Clin Exp Immunol 1992 ; 88: 75-83.

Hirohata S. , Miyamoto T. Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum 1990; 33: 644-9.

Horii Y. , Muraguchi A. , Iwano M. et al. Involvement of IL-6 in mesangial proliferative glomerulonephritis . J Immunol 1989; 143: 3949-55.

Horii Y. , Iwano M. , Hirata E. et al. Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis. Kidney Int 1993; 39: S71-S75.

Taga T. , Hibi M. , Hirata Y. et al. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 1989; 58: 573-81.

Jeffes Ewb , Ininns EK , Schmitz KL , Yamamoto RS , Dett CA , Granger GA The presence of antibodies to lymphotoxin and tumor necrosis factor in normal serum. Arthritis Rheum 1989; 32: 1148-52.

Hansen MB , Svenson M. , Diamant M. , Bendtzen K. Anti-interleukin-6 antibodies in normal human serum. Scand J Immunol 1991; 33: 777-81.

Sheeran TP , Roobottom CA , Wanklyn PD , Winkles J. , Richardson KA , Emery P. The effect of bed rest and intra-articular steroids on the acute phase response in rheumatoid arthritis. Clin Exp Rheumatol 1993 ; 11: 49-52.

Baumann H. , Schendel P. Interleukin-11 regulates the hepatic expression of the same plasma protein genes as interleukin-6. J Biol Chem 1991; 266: 20424-7.

Dayer JM , Fennder H. The role of cytokines and their inhibitor in arthritis. Baillier's Clinical Rheumatology 1992; 6: 485-516.

Vigushin DM , Pepys MB , Hawkins PN Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 1993; 91: 1351-7.

Minota S. , Morino N. , Sakurai H. , Yamada A. , Yazaki Y Interrelationship between autoepitope, DNA-binding domain and CRP-binding domain on a histone H1 molecule. Clin Immunol Immunopathol 1993; 66: 269-71.

Berden Jhm. Binding of anti-DNA antibodies to the glomerulus . Lupus 1992; 1 (Suppl. 1): 88.

Emery P. , Luqmani RA The validity of surrogate markers in rheumatic disease. Br J Rheumatol 1993; 32 (Suppl. 3): 3-8.